Alex
At Best Startup Canada we track over 100,000 Canadian startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top British Columbia based VP’ operating in the Pharmaceutical space. If you think a VP’ is missing from this list, feel free to contact our editor on editor@beststartup.ca.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Edith G. McGeer
Foounder,Vice President & Director of Aurin Biotech
Dr. Edith McGeer is a professor emerita in the Faculty of Medicine at University of British Columbia (UBC). She is the former director of the Kinsmen Laboratory of Neurological Research at UBC. She received her BA from Swarthmore College and her PhD in chemistry from the University of Virginia at the age of 22. She worked for the DuPont Company in Wilmington, Delaware, winning three patents and a citation from the Delaware section of the American Chemical Society before moving with her husband to UBC’s medical school. She has served on the editorial boards of 15 international journals in the neuroscience field. She has recently been on numerous scientific review boards, particularly for the National Institutes of Health (NIH) in the United States, and was one of the initial members of the Executive Committee of the World Federation of Neurology Group on the Dementias. She is an Officer of the Order of Canada, a Fellow of the Royal Society of Canada, a member of the Order of British Columbia and the recipient of three honorary degrees. She is the author of 525 scientific articles, 10 patents, an author of the textbook Molecular Neurobiology of the Mammalian Brain with her husband Dr. Patrick McGeer and Sir John Eccles. The McGeers were both original members of the Highly Cited Researchers database of the ISI, being among the world’ top 100 most highly cited neuroscientists.
Follow Edith G. McGeer:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Mei Mei Tian
Vice President, Head of External Research of Bioasis Technologies
Mei Mei Tian is the VP & Head of External Research at Bioasis Technologies, Inc.
Follow Mei Mei Tian:
About Bioasis Technologies: Bioasis Technologies, Inc. is a biopharmaceutical company.
Iman Mansoor
Vice President of Engineering and Innovation of Microdermics
Iman has been involved in research and development of microneedles for more than 8 years. He received his bachelor’s degree in mechanical engineering (mechatronics option) in 2007 and his master’s and Ph.D. degrees in electrical engineering in 2009 and 2014, respectively, from the University of British Columbia (UBC), Vancouver, BC, Canada. He also received a sub-specialization certificate in Engineering Management and Technology Entrepreneurship in 2013 from UBC. Iman’s graduate research was in the field of Microelectromechanical Systems (MEMS) and mainly focused on process development and characterization of microneedle devices for intradermal drug delivery and biosensing applications. He currently holds a patent on the microneedle fabrication process developed during his graduate research. Since 2014, Iman has worked as Systems Consultant and Product Development Specialist in major engineering companies and has completed several successfully-commercialized projects. During this period, he has also been active in further development and commercialization of microneedle devices.
Follow Iman Mansoor:
About Microdermics: Unlocking continuous biochemical data for clinically relevant insights.
Sahan Ranamukhaarachchi
Co-founder, Vice President of Research & Development of Microdermics
Follow Sahan Ranamukhaarachchi:
About Microdermics: Unlocking continuous biochemical data for clinically relevant insights.
Jason Crawford
Vice President, Scientific Operations of Centre for Drug Research and Development
As the Vice-President of Scientific Operations at The Centre for Drug Research and Development (CDRD), Canada’s fully-integrated national drug development and commercialization centre, Jason plays a key role in the evaluation of potential drug development projects to be incubated within CDRD, and holds responsibility for the successful execution of all subsequent project development plans, and thus the overall management of CDRD’s scientific resources. Prior to assuming this role, he was Head of Medicinal Chemistry at CDRD, having joined the organization in 2008. Previously, from 1999-2007, he held a series of increasingly-senior positions at AnorMED Inc. – initially a Medicinal Chemist, and eventually the Manager of the Development Chemistry Group, leading the synthetic development of all lead and candidate compounds intended for use in pre-clinical and clinical trials. Notably, for plerixafor, which now generates over $150 million annually in global sales as Mozobil, he oversaw the technical transfer of the development process to a contract research organization, the subsequent clinical manufacture, and the eventual validation of the manufacturing process for commercial use. He also acted concurrently as an interdisciplinary project team leader for a clinical-stage anti-HIV therapeutic.
Follow Jason Crawford:
About Centre for Drug Research and Development: The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.
GIPHY App Key not set. Please check settings